Abstract
Progress in the science and practice of medicine requires leveraging financial resources to pursue ideas, achieve new goals, and extend professional objectives. These resources are generally allocated through agencies that function through peer review. The need to onvince a reviewing body, funding agency, or philanhropic foundation that these collective plans merit support s, therefore, a rate-limiting step. Herein I outline perspecives gained over years of writing and reviewing grants, and uggest themes to incorporate and traps to avoid in naviating this process. I focus the discussion on federal grant pplications—specifically, independent investigator-initiated R01) applications— commenting where relevant on entored-type (K) award applications. The commonlities among these applications serves as a focal point.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have